Biocon has announced several corporate actions, including press releases, disclosures under SEBI regulations, and qualified institutions placements. The company has announced final dividends in the ...
Stay on top of the latest tech trends and biggest startup news.
Earnings call Biocon reported 9% YoY revenue growth in Q3 FY26, with biosimilars and generics offsetting CRDMO softness. Core EBITDA rose 21% YoY to INR 1,221 crore with a 29% margin, driven by ...
Feb 16 (Reuters) - Biocon is aiming for high-double-digit percentage revenue growth as the Indian pharmaceutical firm prepares to launch generic versions of weight-loss drugs globally even as it ...
Mumbai: Solid YoY performance backed Biocon’s Q3 FY26 results, with revenue from operations increasing to Rupees 4,173 crore from Rupees 3,821 crore in Q3 FY25. The reported net profit jumped ...
Botox is used to treat overactive bladder (OAB) in adults. It’s also approved to treat urinary incontinence caused by certain neurological conditions in adults and children ages 5 years and older. The ...
ImmunityBio Inc. (NASDAQ: IBRX) shares are up on Monday following the company’s announcement of significant revenue growth. • ImmunityBio stock is challenging resistance. Why are IBRX shares at highs?
LONDON, UK / ACCESS Newswire / February 11, 2026 / The global intraoral scanner market is poised for strong and sustained growth through 2035, driven by the rapid adoption of digital dentistry ...
Rachel works as a CRNA where she provides anesthesia care across the lifespan, including pediatric anesthesia, with a primary focus on orthopedic anesthesia. She is also an Assistant Professor at the ...
Hydronephrosis is when your kidneys swell because your body can't release all of its pee. It may affect one or both kidneys, and it can occur in people of all ages. About 1 in 100 adults get ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果